Literature DB >> 20386308

Age-, sex-, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trials.

Colin R Cooke1, Sara E Erickson, Timothy R Watkins, Michael A Matthay, Leonard D Hudson, Gordon D Rubenfeld.   

Abstract

OBJECTIVE: Little is known about the participation of racial/ethnic minorities, women, and the elderly into critical care clinical trials. We sought to characterize the representation of racial and ethnic minorities, women, and older patients in clinical trials of patients with acute lung injury and to determine the reasons for nonenrollment. DESIGN, SETTING, AND PATIENTS: We performed a cross-sectional analysis of pooled screening logs from 44 academic hospitals participating in three multicentered, randomized, controlled trials conducted by the Acute Respiratory Distress Syndrome Network from 1996 to 2005.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We calculated odds ratios of enrollment for age, sex, racial groups, and the odds ratio for the presence of each exclusion criterion by age, sex, and race adjusted for demographics, acute lung injury risk factor, study, and study center. A total of 10.4% of 17,459 screened patients with acute lung injury were enrolled. The median (range) enrollment by center was 15% (2% to 88%). Older patients of both sexes were less likely to be enrolled, but older women were more likely to be enrolled than older men. The adjusted odds ratio (95% confidence interval) for enrollment among men > or =75 yrs of age was 0.59 (0.45 to 0.77) and for women > or =75 yrs of age was 0.45 (0.32 to 0.62) compared with men <35 yrs of age. There were no differences in the likelihood of enrollment among all racial/ethnic groups. Older patients and men were less likely to be enrolled because of medical comorbidity. Among all patients who were not enrolled, black patients and their families refused participation more often than white patients.
CONCLUSIONS: Older patients are less likely to be enrolled in acute lung injury clinical trials. There is no evidence that women or racial/ethnic minorities are underrepresented in acute lung injury clinical trials.

Entities:  

Mesh:

Year:  2010        PMID: 20386308      PMCID: PMC3799957          DOI: 10.1097/CCM.0b013e3181de451b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  33 in total

1.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

2.  Including older people in clinical research.

Authors:  Marion E T McMurdo; Miles D Witham; Neil D Gillespie
Journal:  BMJ       Date:  2005-11-05

3.  Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

Authors:  Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; David Schoenfeld; Herbert P Wiedemann; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

4.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

5.  The effect of age on the development and outcome of adult sepsis.

Authors:  Greg S Martin; David M Mannino; Marc Moss
Journal:  Crit Care Med       Date:  2006-01       Impact factor: 7.598

Review 6.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

Review 7.  Why African Americans may not be participating in clinical trials.

Authors:  Y Harris; P B Gorelick; P Samuels; I Bempong
Journal:  J Natl Med Assoc       Date:  1996-10       Impact factor: 1.798

8.  Exclusion of elderly people from clinical research: a descriptive study of published reports.

Authors:  G Bugeja; A Kumar; A K Banerjee
Journal:  BMJ       Date:  1997-10-25

Review 9.  Why are African Americans under-represented in medical research studies? Impediments to participation.

Authors:  V L Shavers-Hornaday; C F Lynch; L F Burmeister; J C Torner
Journal:  Ethn Health       Date:  1997 Mar-Jun       Impact factor: 2.772

10.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

View more
  15 in total

Review 1.  Healthcare disparities in critical illness.

Authors:  Graciela J Soto; Greg S Martin; Michelle Ng Gong
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

2.  A Randomized Controlled Trial of Behavioral Nudges to Improve Enrollment in Critical Care Trials.

Authors:  Dustin C Krutsinger; Kelly L O'Leary; Susan S Ellenberg; Cody E Cotner; Scott D Halpern; Katherine R Courtright
Journal:  Ann Am Thorac Soc       Date:  2020-09

Review 3.  Pathways, Contributors, and Correlates of Functional Limitation Across Specialties: Workshop Summary.

Authors:  Stephen B Kritchevsky; Daniel E Forman; Kathryn E Callahan; E Wesley Ely; Kevin P High; Frances McFarland; Eliseo J Pérez-Stable; Kenneth E Schmader; Stephanie A Studenski; John Williams; Susan Zieman; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-03-14       Impact factor: 6.053

4.  Short-term mortality prediction for acute lung injury patients: external validation of the Acute Respiratory Distress Syndrome Network prediction model.

Authors:  Abdulla Damluji; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Jonathan E Sevransky; Eddy Fan; Carl Shanholtz; Margaret Wojnar; Peter J Pronovost; Dale M Needham
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

5.  Health-care system distrust in the intensive care unit.

Authors:  Yael Schenker; Douglas B White; David A Asch; Jeremy M Kahn
Journal:  J Crit Care       Date:  2011-06-28       Impact factor: 3.425

6.  Research participants' opinions of delayed consent for a randomised controlled trial of glucose control in intensive care.

Authors:  J E Potter; S McKinley; A Delaney
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

7.  The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.

Authors:  Marie Méan; Marc Righini; Kurt Jaeger; Hans-Jürg Beer; Beat Frauchiger; Joseph Osterwalder; Nils Kucher; Bernhard Lämmle; Jacques Cornuz; Anne Angelillo-Scherrer; Nicolas Rodondi; Andreas Limacher; Sven Trelle; Christian M Matter; Marc Husmann; Martin Banyai; Markus Aschwanden; Michael Egloff; Lucia Mazzolai; Olivier Hugli; Henri Bounameaux; Drahomir Aujesky
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

8.  Randomized trials in emergency medicine journals, 2008 to 2011.

Authors:  Christopher W Jones; Katherine M Hunold; Cameron G Isaacs; Timothy F Platts-Mills
Journal:  Am J Emerg Med       Date:  2012-08-04       Impact factor: 2.469

9.  Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome.

Authors:  S Jean Hsieh; Hanjing Zhuo; Neal L Benowitz; B Taylor Thompson; Kathleen D Liu; Michael A Matthay; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

10.  CYCLE pilot: a protocol for a pilot randomised study of early cycle ergometry versus routine physiotherapy in mechanically ventilated patients.

Authors:  Michelle E Kho; Alexander J Molloy; France Clarke; Margaret S Herridge; Karen K Y Koo; Jill Rudkowski; Andrew J E Seely; Joseph R Pellizzari; Jean-Eric Tarride; Marina Mourtzakis; Timothy Karachi; Deborah J Cook
Journal:  BMJ Open       Date:  2016-04-08       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.